Revlimid® Capsules Special Drug Use-results Survey (in Patients With Newly-diagnosed Multiple Myeloma [NDMM])
Clinical trial NCT02741544 · COMPLETED
Trial details
- NCT number
- NCT02741544
- Sponsor
- Celgene
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2016-03-03
- Primary completion
- 2020-08-20
- Enrollment
- 578
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.